Mayinglong Pharmaceutical Group Co., Ltd. (SHA:600993)
China flag China · Delayed Price · Currency is CNY
25.90
-0.06 (-0.23%)
Apr 28, 2026, 3:00 PM CST

SHA:600993 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
11,16412,07011,25510,4239,74212,397
Market Cap Growth
4.65%7.24%7.98%6.99%-21.42%42.80%
Enterprise Value
8,8499,6568,6168,2797,56910,698
Last Close Price
25.9028.0025.5523.3121.4926.92
PE Ratio
18.9020.7621.3123.5220.3626.68
Forward PE
14.3521.8021.8021.8021.8021.80
PS Ratio
2.863.123.023.322.763.66
PB Ratio
2.362.672.682.692.693.74
P/TBV Ratio
2.502.852.852.882.843.99
P/FCF Ratio
18.7325.0938.3129.3036.5123.30
P/OCF Ratio
16.2820.1022.6217.2628.5020.76
PEG Ratio
0.802.642.642.642.642.64
EV/Sales Ratio
2.262.502.312.642.143.16
EV/EBITDA Ratio
11.7013.1013.8519.0713.9921.61
EV/EBIT Ratio
13.1014.4214.9021.5215.3223.60
EV/FCF Ratio
14.8420.0729.3323.2828.3620.11
Debt / Equity Ratio
0.020.020.060.070.180.06
Debt / EBITDA Ratio
0.140.130.360.591.110.35
Debt / FCF Ratio
0.180.210.800.772.390.34
Net Debt / Equity Ratio
-0.52-0.55-0.70-0.72-0.74-0.75
Net Debt / EBITDA Ratio
-3.28-3.38-4.70-6.40-4.93-5.04
Net Debt / FCF Ratio
-4.12-5.19-9.95-7.81-10.00-4.69
Asset Turnover
0.710.730.750.630.770.85
Inventory Turnover
7.436.577.256.006.276.94
Quick Ratio
4.524.434.545.034.384.43
Current Ratio
5.064.964.945.544.925.05
Return on Equity (ROE)
13.45%13.90%13.59%12.07%13.83%15.14%
Return on Assets (ROA)
7.62%7.88%7.22%4.85%6.70%7.09%
Return on Invested Capital (ROIC)
26.95%34.70%40.72%32.51%47.99%49.86%
Return on Capital Employed (ROCE)
13.80%14.30%13.20%9.30%11.70%13.10%
Earnings Yield
5.29%4.82%4.69%4.25%4.91%3.75%
FCF Yield
5.34%3.99%2.61%3.41%2.74%4.29%
Dividend Yield
2.39%-2.43%1.72%1.63%1.30%
Payout Ratio
45.64%46.37%33.57%36.71%34.49%26.80%
Buyback Yield / Dilution
-0.17%-0.32%0.23%0.19%-0.22%0.43%
Total Shareholder Return
2.22%-0.32%2.66%1.90%1.40%1.73%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.